Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment

Adocia announces 2021 fourth quarter financial results

dievini and related parties underline their strong commitment as shareholders of CureVac N.V. and do no longer plan to sell shares to the public

Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients

Secarna Pharmaceuticals’ partner Denali Therapeutics exercises option for LNAplusTM antisense oligonucleotide development program in neurodegeneration

InflaRx Reports Progress in Ongoing Phase II Clinical Trial with Vilobelimab in Cutaneous Squamous Cell Carcinoma

Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer

Marinomed receives € 6 m with final tranche of financing agreement with EIB to invest in proprietary R&D pipeline

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus

Lindis Blood Care successfully closes follow-on financing round